Glenmark Pharmaceuticals Ltd

GLENMARK

Company Profile

  • Business description

    Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe and the Rest of the world.

  • Contact

    B. D. Sawant Marg
    Glenmark House
    Chakala, Off Western Express Highway
    Andheri (East)
    MumbaiMH400099
    IND

    T: +91 2240189999

    E: [email protected]

    https://www.glenmarkpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    16,623

Stocks News & Analysis

stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.
stocks

3 cheap fully franked stocks

Discounted Aussie shares that offer a tax rebate.
stocks

SpaceX jumps 19% in debut, but hurdles lie ahead

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,128.0014.600.16%
CAC 408,456.38105.511.26%
DAX 4025,014.86379.561.54%
Dow JONES (US)51,202.26353.510.70%
FTSE 10010,520.2348.510.46%
HKSE24,831.00112.900.46%
NASDAQ25,888.8479.180.31%
Nikkei 22569,317.503,297.464.99%
NZX 50 Index13,360.5933.28-0.25%
S&P 5007,431.4637.160.50%
S&P/ASX 2008,914.007.000.08%
SSE Composite Index4,096.4764.961.61%

Market Movers